Member Info for Tra1

Traded Action Notifier Price Amount Value

08-Dec-20 Placing Douglas Robertson 10.00p 19,839 £1,983.90
08-Dec-20 Placing Amanda Burton 10.00p 74,404 £7,440.40
08-Dec-20 Placing Paul Quested 10.00p 97,916 £9,791.60
08-Dec-20 Placing Steve Ashmore 10.00p 653,081 £65,308.10
08-Dec-20 Placing Alan Peterson 10.00p 1,842,483 £184,248.30

Total = £268,770 Directors buy

@tutter, yes we have been looking at these triangles, but i wonder if r actually looking at a much bigger time frame (from 2013) -:)) just for fun, the bigger triangle and a zoom in, anyway make sure you are here by the end of Dec. that is where all the T lines intersects =:)

https://invst.ly/t2bcc

https://invst.ly/t2bdv

actually, the placing price has gone since 19/10

the news will suit the chart and vice versa, the dilution over the years is also built in the chart with the LHs and LLs, but for now it is a good buy opportunity with low risk, let us see

strong support here since 2015, buy zone TP 10+ possible 15+ it does not matter how long it takes, ATB__
https://invst.ly/t28a6

they will not give any updates. You can see clearly they do not want to put their name any written communications (in case the investors start to take an action. All verbal noise through a third party or shop front called T..

ceo interview__

https://www.proactiveinvestors.com/companies/news/928405/julian-wheatland-is-appointed-new-ceo-of-cornerstone-after-company-buys-fxpress-928405.html

That is what you need to compare our trial with:

Dorzagliatin is a Glucokinase activator (same as AZD1656) once it was approved for diabetic use, Bayer was keen to have an exclusive agreement (article below)
We are currently testing its benefits/indication for Diabetics/suffering from covid and I expect a similar agreement with Astrazeneca once we have the results.

https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/bayer-obtains-exclusive-rights-to-market-hua-medicine-s-diabetes-drug-in-china-59957967

I see, CExaminer is back with with a new account..

Good news from mode now____(London, 2nd December) - Mode Global Holdings, the LSE-listed fintech group, reports that trading volumes surged 950% in November compared to August and assets under custody increased by 210%, as more customers used the Mode app to buy and hold Bitcoin. 80% of these trades were purchases.

the bod is excited about the target..
the bod is optimistic about the target..
the bod is cautiously optimistic..
the bod is v very cautiously optimistic..
AIM is asking for more details
the lse is putting hurdles
We have done everything we can/not our fault (never)..
the bod is not optimistic..

-My early (late) f r a u d detection test is flashing red

ah, thanks Prosper, i did not realise they r listed, z r up 9%, good to know

it seems that one of our investments is doing well with the bounce in Gold price as well__https://www.investing.com/equities/btl-group-ltd-chart

not telling anyone to buy or sell, but this has bottomed and reversing now..

@ATG, yep ready to go (although i do not mind these prices until tomorrow so i can add -:), Ichi cloud points to rise soon, 4h chart shows bullish divergence, currently in consolidation zone, same as 19/10, just removed some indicators for clarity, dyor _ https://invst.ly/s-d2u

yes CExaminer you ve been "quite vocal” = repeating the same sentence every few minutes. Perhaps if you submit a chart or any useful info, people will start taking your posts seriously.

GKA never been tested on Covid pts with DM and Arcadia will be the first trial to prove its benefits in these patients

Interesting weekend reading, shows that GKI is safe and efficient in DM, once our study is completed I expect an agreement similar to the one listed in the last paragraph, as i said before this could be a company making in its own.
SGSC i hope you are reading this bb -:)

https://www.biospectrumasia.com/news/48/16551/hua-medicine-bayer-bring-novel-diabetes-treatment-in-china.html

P.S. dorzagliatin = glucokinase activator

that is not right but up to you

well, definitely not getting any cheaper for anyone who wants to buy or average down